The BLOC1S5 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population derived from the human colorectal adenocarcinoma line HT29, featuring disruption of the BLOC1S5 gene. This product provides a pooled knockout model with a heterogeneous genetic background, avoiding clonal selection bias. The CRISPR-mediated gene disruption results in loss of functional BLOC1S5 protein, enabling studies of BLOC-1 complex-dependent processes in an epithelial context.
HT29 cells originate from a primary colorectal adenocarcinoma of a female patient and are an established model for intestinal epithelial biology, colorectal cancer, and barrier function. These cells maintain epithelial characteristics and the ability to polarize and differentiate, making them suitable for investigating membrane trafficking pathways relevant to gut physiology and tumorigenesis.
BLOC1S5 is a subunit of the biogenesis of lysosome-related organelles complex-1 (BLOC-1), which sorts cargo from early endosomes to lysosome-related organelles such as melanosomes and platelet dense granules. BLOC-1 acts upstream of the AP-3 complex and is regulated by Rab32 and Rab38 GTPases. Key cargoes include tyrosinase (TYR) and TYRP1. BLOC1S5 directly interacts with other BLOC-1 subunits (BLOC1S1, BLOC1S2, BLOC1S3, BLOC1S4, BLOC1S6, DTNBP1, PLDN) and with clathrin and SNARE proteins to coordinate vesicle trafficking. Loss of BLOC1S5 disrupts these routes, mirroring defects seen in Hermansky-Pudlak syndrome type 11, which involves oculocutaneous albinism and bleeding diathesis.
In HT29 cells, BLOC1S5 knockout provides a relevant epithelial platform to study how BLOC-1 dysfunction impacts endosomal sorting and organelle biogenesis in a cancer cell background. Although HT29 cells lack melanosomes, conserved trafficking machineries govern processes such as receptor recycling, cell polarity, and exosome secretion??pathways often aberrant in colorectal cancer. This model thus facilitates analysis of BLOC-1??s role in tumor cell trafficking and may reveal vulnerabilities associated with lysosome-related organelle pathway defects.
Typical applications include investigating lysosome-related organelle biogenesis mechanisms in epithelia, assessing endosomal trafficking alterations in cancer, and modeling Hermansky-Pudlak syndrome cellular phenotypes. Suitable assays encompass Western blotting for BLOC-1 components, immunofluorescence for endosomal markers, co-immunoprecipitation of the complex, endocytosis/recycling assays, RNA-seq, and transmission electron microscopy. For inquiries and custom study designs, please contact Ascent Research.
